Myrobalan News

Press Release Oct 31, 2024

Myrobalan Therapeutics Appoints Robin Kleiman Ph.D., as Chief Scientific Officer

Read more

Press Release Oct 16, 2024

Myrobalan Therapeutics Strengthens Board of Directors with Appointment of Emma Reeve

Read more

Press Release Sep 18, 2024

Myrobalan Presents GPR17 Antagonist Preclinical Data at ECTRIMS 2024

Read more

Press Release Jul 29, 2024

Myrobalan Therapeutics Names Grant Bogle to Board of Directors

Read more

Press Release Feb 7, 2024

Myrobalan Therapeutics Receives a Grant from the ALS Association to Advance its CSF1R Inhibitor Program

Read more

Press Release Jan 10, 2024

Myrobalan Therapeutics Completes Series A Financing of $24 Million to Develop Potentially First-in-Class CNS Therapeutics with Restorative Potential

Read more